Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
Bay Area General Counsel RoundtableThursday, September 24, 2026DOJ Rule Filing Helps Make White Collar Fraud Enforcement Restructuring FinalAugust 21, 2026OCC Proposes Easing Non-Public Information Disclosure Rules and Removing Criminal Penalty ReferencesAugust 20, 2026Sidley Represents Stone Point Capital in Acquisition of Ever.Ag’s Risk Management BusinessAugust 20, 2026Second Circuit Clarifies Scope of “Property” that an FCA “Claim” May SeekAugust 17, 2026U.S. FinCEN Issues Final Rule Ending Beneficial Ownership Reporting RequirementAugust 17, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory